Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorÇakır, Habib
dc.contributor.authorUncu, Hasan
dc.contributor.authorGür, Özcan
dc.contributor.authorÖzkaramanlı Gür, Demet
dc.contributor.authorYürekli, İsmail
dc.contributor.authorİbrahim, Özsöyler
dc.date.accessioned2022-05-11T14:35:58Z
dc.date.available2022-05-11T14:35:58Z
dc.date.issued2014
dc.identifier.issn1899-5276
dc.identifier.issn2451-2680
dc.identifier.urihttps://doi.org/10.17219/acem/37070
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8317
dc.description.abstractObjectives. The study was aimed at investigating the risk factors of using an intraaortic balloon pump (IABP) in coronary artery bypass surgery and presenting the authors' clinical experience of IABP use. Material and Methods. The study included 1094 patients who underwent coronary artery bypass surgery at the authors' clinic between January 2009 and December 2011. A comparison was made between 17 patients in whom an IABP was used and 1077 patients in whom it was not used. Results. An intraaortic balloon pump was used in 17 patients (1.55%) out of 1094 patients who underwent isolated coronary artery bypass surgery. The ratio of patients who had had preoperative myocardial infarction within the preceding 30 days, left main coronary artery stenosis of more than 50% and emergency surgery in Group 1 were higher than in Group 2 (p < 0.05). The total cardiopulmonary bypass time of Group 1 was found to be longer than that of Group 2 (p < 0.05). The demand for inotropics after weaning from cardiopulmonary bypass was greater in Group 1 than in Group 2 (p < 0.05). The need for reoperation (because of bleeding) was higher in Group 1 than in Group 2 (p < 0.05). The patients' stay on the intensive care unit was longer in Group 1 than in Group 2 (p < 0.05). Mortality rates were 29.4% in Group 1 and 1.2% in Group 2 (p < 0.05). Conclusions. Preoperative myocardial infarction within the preceding 30 days, left main coronary artery stenosis of more than 50%, emergency surgery and long cardiopulmonary bypass time are important risk factors for IABP use in coronary artery bypass surgery (Adv Clin Exp Med 2014, 23, 2, 253-257).en_US
dc.language.isoengen_US
dc.publisherWroclaw Medical Univen_US
dc.identifier.doi10.17219/acem/37070
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectintraaortic balloon pumpen_US
dc.subjectcoronary artery bypass surgeryen_US
dc.subjectmortalityen_US
dc.subjectCardiac-Surgeryen_US
dc.subjectCounterpulsationen_US
dc.subjectComplicationsen_US
dc.subjectSupporten_US
dc.titleRisk Factors for Intraaortic Balloon Pump Use in Coronary Artery Bypass Surgeryen_US
dc.typearticleen_US
dc.relation.ispartofAdvances in Clinical and Experimental Medicineen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kalp ve Damar Cerrahisi Ana Bilim Dalıen_US
dc.identifier.volume23en_US
dc.identifier.issue2en_US
dc.identifier.startpage253en_US
dc.identifier.endpage257en_US
dc.institutionauthorGür, Özcan
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid6602782113
dc.authorscopusid6602633579
dc.authorscopusid10139012600
dc.authorscopusid55317577700
dc.authorscopusid8894567000
dc.authorscopusid57202636730
dc.authorwosidgur, ozcan/AAA-8847-2022
dc.identifier.wosWOS:000335375500013en_US
dc.identifier.scopus2-s2.0-84902181399en_US
dc.identifier.pmid24913116en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster